In Other Journals

Sophie McNamara
Med J Aust 2011; 195 (2): . || doi: 10.5694/j.1326-5377.2011.tb03222.x
Published online: 18 July 2011

Exposure to selective serotonin reuptake inhibitors (SSRIs) during pregnancy may increase the risk of autism spectrum disorders (ASD), according to a study of 298 children with ASD and 1507 control children. The population-based, case-controlled study is the first to systematically address the association between prenatal SSRIs and ASD risk. The researchers found that children whose mothers took SSRI antidepressants in the year before delivery were twice as likely to develop ASD. SSRI use in the first trimester was associated with a threefold increased risk.

  • Sophie McNamara



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.